Toward the characterization and identification of γ-secretases using transition-state analogue inhibitors

Annals of the New York Academy of Sciences

Volumn 920, Issue , 2000, Pages 197-205

  Moore, Chad L ^a   Diehl, Thekla S ^b   Selkoe, Dennis J ^b   Wolfe, Michael S ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; GAMMA SECRETASE;

ANIMAL CELL; AUTOSOMAL DOMINANT DISORDER; CARBOXY TERMINAL SEQUENCE; CONFERENCE PAPER; COVALENT BOND; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ANALYSIS; HYDROPHOBICITY; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DOMAIN; RECEPTOR BLOCKING; SITE DIRECTED MUTAGENESIS;

ANIMALIA;

EID: 0034528028     PISSN: 00778923     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1749-6632.2000.tb06922.x     Document Type: Article

References (39)

1. Translating cell biology into therapeutic advances in Alzheimer's disease
2. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red
3. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease
4. The Alzheimer family of diseases: Many etiologies, one pathogenesis?
5. Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome
6. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE
7. Purification and cloning of amyloid precursor protein beta-secretase from human brain
8. Membrane-anchored aspartyl protease with Alzheimer's disease beta- secretase activity
9. Identification of a novel aspartic protease (Asp 2) as beta-secretase
10. Peptidomimetic probes and molecular modeling suggest Alzheimer's γ-secretases are intramembrane-cleaving aspartyl proteases
11. Mechanism of the cleavage specificity of Alzheimer's disease gamma-secretase identified by phenylalanine-scanning mutagenesis of the transmembrane domain of the amyloid precursor protein
12. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity
13. A loss of function mutation of presenilin-2 interferes with amyloid beta-peptide production and notch signaling
14. Are presenilins intramembrane-cleaving proteases? Implications for the molecular mechanism of Alzheimer's disease
15. Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors
16. A substrate-based difluoro ketone selectively inhibits Alzheimer's gamma-secretase activity
17. Enhanced production and oligomerization of the 42-residue amyloid beta-protein by Chinese hamster ovary cells stably expressing mutant presenilins
18. Amyloid precursor protein processing and A beta 42 deposition in a transgenic mouse model of Alzheimer disease
19. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids
20. Familial Alzheimer's disease-linked mutations at Val717 of amyloid precursor protein are specific for the increased secretion of A beta 42(43)
21. Beta-amyloid precursor protein: Location of transmembrane domain and specificity of gamma-secretase cleavage
22. Mutations in the transmembrane domain of APP altering gamma-secretase specificity
23. Inhibition of chymotrypsin by fluorinated alphaketo acid derivatives
24. Inactivation of calpain by peptidyl fluoromethyl ketones
25. Design and synthesis of potent and specific renin inhibitors containing difluorostatine, difluorostatone, and related analogues
26. Design and synthesis of potent, selective, and orally active fluorine-containing renin inhibitors
27. Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities
28. The carboxyl termini of beta-amyloid peptides 1-40 and 1-42 are generated by distinct gamma-secretase activities
29. Inhibition of beta-amyloid formation identifies proteolytic precursors and subcellular site of catabolism
30. A combinatorial approach to the identification of dipeptide aldehyde inhibitors of beta-amyloid production
31. Calpain inhibitor I increases beta-amyloid peptide production by inhibiting the degradation of the substrate of gamma-secretase: Evidence that substrate availability limits beta-amyloid peptide production
32. Affinity labeling of the ribosomal decoding site with an AUG-substrate analog
33. Affinity labeling of the androgen receptor in rat prostate cytosol with 17 beta-[(bromoacetyl)oxy]-5 alpha-androstan-3-one
34. N-Bromoacetyl-D-leucylglycine: An affinity label for neutral endopeptidase 24.11
35. Selective irreversible inhibitors of aldose reductase
36. Structural requirements of iodothyronines for the rapid inactivation and internalization of type II iodothyronine 5′-deiodinase in glial cells
37. Localization of the affinity peptide-substrate inactivator site on recombinant vitamin K-dependent carboxylase
38. Crystallographic analysis of transition state mimics bound to penicillopepsin: Difluorostatine- and difluorostatone-containing peptides
39. Transition-state analogue inhibitors of γ-secretase bind directly to presenilin-1